Gamidor Diagnostics

Executive Summary

Gamidor Diagnostics, founded in 1985 and headquartered in Tel Aviv, is a leading Israeli distributor of medical diagnostic systems, reagents, and services. Serving clinical laboratories, hospitals, research institutes, and the general public, the company offers a comprehensive portfolio spanning molecular biology, point-of-care devices, clinical chemistry, microbiology, women's health, genetics, and tissue diagnostics. By representing top global manufacturers, Gamidor ensures access to cutting-edge technologies and automation solutions for the Israeli healthcare market. With over three decades of operations and a workforce of 100-200 employees, the company has established a strong local presence and trusted relationships with healthcare providers. As the diagnostics sector grows driven by aging populations and chronic disease prevalence, Gamidor is well-positioned to capture increasing demand through its diversified product range and service expertise. The company's commercial maturity and private status provide operational stability, though financial details remain undisclosed.

Upcoming Catalysts (preview)

• Q3 2026New distribution agreement with a major IVD manufacturer70% success
• Q4 2026Expansion of point-of-care testing portfolio60% success
• 2027Entry into neighboring Middle Eastern markets40% success